Nasso, G.; Vignaroli, W.; Amodeo, V.; Bartolomucci, F.; Larosa, C.; Contegiacomo, G.; Demola, M.A.; Girasoli, C.; Valenzano, A.; Fiore, F.;
et al. Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results. J. Clin. Med. 2024, 13, 2987.
https://doi.org/10.3390/jcm13102987
AMA Style
Nasso G, Vignaroli W, Amodeo V, Bartolomucci F, Larosa C, Contegiacomo G, Demola MA, Girasoli C, Valenzano A, Fiore F,
et al. Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results. Journal of Clinical Medicine. 2024; 13(10):2987.
https://doi.org/10.3390/jcm13102987
Chicago/Turabian Style
Nasso, Giuseppe, Walter Vignaroli, Vincenzo Amodeo, Francesco Bartolomucci, Claudio Larosa, Gaetano Contegiacomo, Maria Antonietta Demola, Cataldo Girasoli, Antongiulio Valenzano, Flavio Fiore,
and et al. 2024. "Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results" Journal of Clinical Medicine 13, no. 10: 2987.
https://doi.org/10.3390/jcm13102987
APA Style
Nasso, G., Vignaroli, W., Amodeo, V., Bartolomucci, F., Larosa, C., Contegiacomo, G., Demola, M. A., Girasoli, C., Valenzano, A., Fiore, F., Bonifazi, R., Triggiani, V., Vitobello, V., Errico, G., Lamanna, A., Hila, D., Loizzo, T., Franchino, R., Sechi, S.,
... Santarpino, G.
(2024). Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results. Journal of Clinical Medicine, 13(10), 2987.
https://doi.org/10.3390/jcm13102987
